Suppr超能文献

间变性甲状腺癌中癌症干细胞标志物及上皮-间质转化相关因子的表达

Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.

作者信息

Jung Chang Won, Han Kang Hee, Seol Hyesil, Park Sunhoo, Koh Jae Soo, Lee Seung-Sook, Kim Min Joo, Choi Ik Joon, Myung Jae Kyung

机构信息

Department of Pathology, Korea Cancer Center Hospital Seoul, Korea.

Department of Pathology, Korea Cancer Center Hospital Seoul, Korea ; Laboratory of Radiation Pathology, Korea Cancer Center Hospital Seoul, Korea.

出版信息

Int J Clin Exp Pathol. 2015 Jan 1;8(1):560-8. eCollection 2015.

Abstract

BACKGROUND

Anaplastic thyroid carcinoma (ATC) is an undifferentiated tumor of the thyroid that has poor prognosis owing to its aggressive behavior and resistance to current treatments. We hypothesized that the stem cell properties induced by the epithelial-mesenchymal transition (EMT) was one of reasons for the dismal outcome of ATC.

MATERIALS AND METHODS

Paraffin blocks and slides of 17 ATC cases were retrieved. We also collected 60 cases of papillary thyroid carcinoma (PTC) for comparison. We used immunohistochemistry to examine the expression of multiple markers of cancer stem cells and EMT-activating transcriptional factors.

RESULTS

Majority of ATC cases showed loss of epithelial (E)-cadherin expression (15/17); however, all PTC cases (60/60) retained E-cadherin expression. EMT-activating transcription factors, such as snail and slug, were more frequently expressed in ATC than PTC cases (35.3% versus 6.7%, 76.5% versus 5%, respectively). Cancer stem cell markers such as CD133 and nestin were more highly expressed in ATC than PTC (52.9% versus 5%, 52.9% versus 0%, respectively).

CONCLUSION

We found that the expression of EMT-related factors and stem cell markers was higher in ATC than PTC. We therefore conclude that stemness induced by EMT plays an important role in the pathogenesis of ATC.

摘要

背景

间变性甲状腺癌(ATC)是一种甲状腺未分化肿瘤,因其侵袭性生物学行为和对现有治疗的抵抗性而预后较差。我们推测,上皮-间质转化(EMT)诱导的干细胞特性是ATC预后不良的原因之一。

材料与方法

收集17例ATC病例的石蜡块和切片。我们还收集了60例甲状腺乳头状癌(PTC)病例用于比较。我们采用免疫组织化学法检测癌干细胞和EMT激活转录因子多种标志物的表达。

结果

大多数ATC病例显示上皮型(E)-钙黏蛋白表达缺失(15/17);然而,所有PTC病例(60/60)均保留E-钙黏蛋白表达。EMT激活转录因子,如蜗牛蛋白和蛞蝓蛋白,在ATC病例中的表达频率高于PTC病例(分别为35.3%对6.7%,76.5%对5%)。癌干细胞标志物如CD133和巢蛋白在ATC中的表达高于PTC(分别为52.9%对5%,52.9%对0%)。

结论

我们发现EMT相关因子和干细胞标志物在ATC中的表达高于PTC。因此,我们得出结论,EMT诱导的干性在ATC发病机制中起重要作用。

相似文献

3
Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
Bull Cancer. 2017 May;104(5):433-441. doi: 10.1016/j.bulcan.2016.12.001. Epub 2017 Feb 6.
5
The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.
Cancer Res Treat. 2017 Apr;49(2):509-517. doi: 10.4143/crt.2016.214. Epub 2016 Sep 1.
6
The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.
Endocr Pathol. 2013 Dec;24(4):206-12. doi: 10.1007/s12022-013-9272-9.
7
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.
J Korean Med Sci. 2017 Oct;32(10):1721-1726. doi: 10.3346/jkms.2017.32.10.1721.
8
Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Life Sci. 2016 Feb 1;146:34-9. doi: 10.1016/j.lfs.2015.12.057. Epub 2016 Jan 7.
9
Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells.
Neoplasia. 2018 Feb;20(2):197-206. doi: 10.1016/j.neo.2017.12.003. Epub 2018 Jan 12.
10
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer.
Cells. 2019 Jun 6;8(6):547. doi: 10.3390/cells8060547.

引用本文的文献

1
Acute chromatin decompaction stiffens the nucleus as revealed by nanopillar-induced nuclear deformation in cells.
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2416659122. doi: 10.1073/pnas.2416659122. Epub 2025 May 9.
2
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics.
J Exp Clin Cancer Res. 2024 Mar 19;43(1):85. doi: 10.1186/s13046-024-03009-8.
3
Harnessing cancer stem cell-derived exosomes to improve cancer therapy.
J Exp Clin Cancer Res. 2023 May 23;42(1):131. doi: 10.1186/s13046-023-02717-x.
5
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer.
J Exp Clin Cancer Res. 2022 Mar 25;41(1):108. doi: 10.1186/s13046-022-02316-2.
6
Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers.
Medicina (Kaunas). 2021 Oct 19;57(10):1131. doi: 10.3390/medicina57101131.
7
Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.
Pathol Oncol Res. 2021 Apr 30;27:609472. doi: 10.3389/pore.2021.609472. eCollection 2021.
10
Knockdown of Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375.
Cancer Manag Res. 2020 Sep 22;12:8757-8771. doi: 10.2147/CMAR.S243767. eCollection 2020.

本文引用的文献

1
New therapeutic options for advanced forms of thyroid cancer.
Expert Opin Emerg Drugs. 2014 Jun;19(2):225-41. doi: 10.1517/14728214.2014.894017. Epub 2014 Mar 3.
2
The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.
Endocr Pathol. 2013 Dec;24(4):206-12. doi: 10.1007/s12022-013-9272-9.
3
Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
Hum Pathol. 2013 Sep;44(9):1707-13. doi: 10.1016/j.humpath.2013.01.009. Epub 2013 Mar 22.
4
Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
Mod Pathol. 2013 Jan;26(1):54-61. doi: 10.1038/modpathol.2012.137. Epub 2012 Aug 17.
6
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
Pathology. 2011 Aug;43(5):447-52. doi: 10.1097/PAT.0b013e3283486178.
8
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
J Clin Endocrinol Metab. 2011 May;96(5):E772-81. doi: 10.1210/jc.2010-1182. Epub 2011 Mar 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验